Growth hormone, growth factors and hematopoiesis

Hormone Research in Paediatrics

Volumn 45, Issue 1-2, 1996, Pages 38-45

  Kelley, Keith W ^a   Dantzer, Robert ^b   Minshall, Christian ^a   Liu, Qiang ^a  

^a UNIVERSITY OF ILLINOIS AT URBANA CHAMPAIGN   (United States)

^b INSERM   (France)

Author keywords

Apoptosis; Colony stimulating factors; IGF 1; Myeloid cells

Indexed keywords

COLONY STIMULATING FACTOR 1; GROWTH FACTOR; GROWTH HORMONE; INTERLEUKIN 3; SOMATOMEDIN BINDING PROTEIN 3; SOMATOMEDIN C;

AGING; APOPTOSIS; BONE MARROW; BONE MARROW CELL; CELL DEATH; CELL DIFFERENTIATION; CELL PROLIFERATION; CONFERENCE PAPER; ERYTHROID CELL; GROWTH HORMONE RELEASE; HEMATOPOIESIS; HEMATOPOIETIC CELL; HUMAN; HYPOPHYSECTOMY; HYPOPHYSIS CELL; LYMPHOID CELL; LYMPHOID ORGAN; NONHUMAN; PRIORITY JOURNAL; PROMYELOCYTE; PROTEIN EXPRESSION; PROTEIN SYNTHESIS; THYMUS;

AGING; ANIMALS; DWARFISM; GROWTH HORMONE; GROWTH SUBSTANCES; HEMATOPOIESIS; HEMATOPOIETIC STEM CELLS; HUMANS; HYPOPHYSECTOMY; INSULIN-LIKE GROWTH FACTOR I; INTERLEUKIN-3; MACROPHAGE COLONY-STIMULATING FACTOR; MICE; RODENTIA;

EID: 0030026240     PISSN: 16632818     EISSN: 16632826     Source Type: Journal    
DOI: 10.1159/000184757     Document Type: Article

References (91)

1. Corpus E, Harman SM, Blackman MR: Human growth hormone and human aging, Endocr Rev 1993; 14:20-39.
2. Abhasi AA, Ridman D: Effects of human growth hormone in older adults: in Shiverick KT, Rosenbloom AL (eds): Human Growth Hormone Pharmacology, Basic and Clinical Aspects, Boca Raton, CRC Press, 1995. pp 121-140.
3. Rudman B, Feller AG, Nagraf HS, Gergans GA, Lalitha PY, Goldberg AF, Schlenker RA, Cohn I, Rudman IW: Effects of human growth hormone in men over 60 years old, N Engl J Med 1990:323:1-6.
4. Kelley KVV, Brief S, Weslly HJ, Novakofski J, Bechtel PJ, Simon J, Walker EB: GH pituitary adenoma cells can reverse thymic aging in rats, Proc Natl Acad Sei ESA 1986:83:5663-5667.
5. Bcrezi I, Nagy E: The effect of prolactin and growth hormone on hemolymphopoictic tissue and immune function; in Berczi I, Kovacs K (eds): Hormones and Immunity, Lancaster, MTP, 1987. pp 145-171.
6. Bcrezi I: The role of the growth and lactogenic hormone family in immune function, Neuro-immunomodulation 1994:1:201-216.
7. Kelley KW, Arkins S, Li YM: Growth hormone, prolactin, and insulin-like growth factors: New jobs for old players, Brain Behav Immun 1992:6:317-326.
8. Ercn R, Gloherxon A, Abel L, Zharhary D: Quantitative analysis of bone marrow thymic progenitors in young and aged mice, Cell Immunol 1990:127:238-246.
9. Sharp A, Kukulansky T, Globerson A: In vitro analysis of age-related changes in the developmental potential of bone marrow thymocyte progenitors, Eur J Immunol 1990:20: 2541-2546.
10. Knyszynski A, Adler-Kunin S, Globerson A: Effects of growth hormone on thymocyte development from progenitor cells in the bone marrow, Brain Bchav linmun 1992:6: 327-340.
11. Clark R, Strasser J, McCabe S, Robbins K, Jar-dien P: Insulin-like growth factor-1 stimulation of lymphopoiesis, J Clin Invest 1993:92: 540-548.
12. McCormick KR, Haar JL, Tauherbcrger JK, Krieg RJ: A murine model for regeneration of the senescent thymus using growth hormone therapy, Aging, Immunol Infect Dis 1991:3: 19-26.
13. Goff BL, Roth J A, Arp LH, Incefy GS: Growth hormone treatment stimulates thymulin production in aged dogs, Clin Exp Immunol 1987; 68:580-587.
14. Goya RG, Gagnerault MC, Leite de Moraes MC, Savino W, Dardennc M: In vivo effects of growth hormone on thymus function in aging mice, Brain Bellas linmun 1992:6:341-354.
15. Murphy WJ, Durum SK, Longo DL: The role of neuroendocrine hormones in murine T cell development: Growth hormone exerts thymo-poietic effects in vivo, J Immunol 1992:149: 3851-3857.
16. Murphy WJ, Durum SK, Anver MR, Longo DL: Immunologic and hematologic effects of neuroendocrine hormones, Studies on DW/J dwarf mice, J Immunol 1992:148:3799-3805.
17. Murphy WJ, Durum SK, Longo DL: Differential effects of growth hormone and prolactin on murine T cell development and function, J Exp Med 1993:178:231-236.
18. Murphy WJ, Durum SK, Longo DL: Human growth hormone promotes engraftment of murine or human T cells in severe combined immunodeficient mice, Proc Natl Acad Sci USA 1992:89:4481-4485.
19. Murphy WJ, Durum SK, Anver M, Frazier M, Longo DL: Recombinant human growth hormone promotes human lymphocyte engraftment in immunodeficient mice and results in an increased incidence of human Epstein Ban virus-induced B-cell lymphoma, Brain Behav Immun 1992:6:355-364.
20. Berczi I, Nagy E, deToledo SM, Matusik RJ, Friesen HG: Pituitary hormones regulate c-myc and DNA synthesis in lymphoid tissue, J Immunol 1991:146:2201-2206.
21. Crilly PJ, Johnston PC, Gardner MJ, Flint DJ: Immunoneutralisation of GH in neonatal rats results in defects in lymphatic tissues and the humoral immune response, Endocrine J 1994: 2:105-109.
22. Beschomer WE, Divic J, Pulido H, Yao X, Kenworthy P, Bruce G: Enhancement of thymic recovery after cyelosporinc by recombinant human growth hormone and insulin-like growth factor I, Transplantation 1991:52: 879-884.
23. Murphy WJ, Tsarfaty G, Longo DL: Growth hormone exerts hematopoietic growth-promoting effects in vivo and partially counteracts the myelosuppressive effects of azidothymi-dine, Blood 1992:80:1433-1447.
24. Ban E, Gagnerault MC, Jammcs H, Postel-Vinav MC, Haour F, Dardenne M: Specific binding sites for growth hormone in cultured mouse thymic epithelial cells, Life Sci 1991: 48:2141-2148.
25. Timsil J, Savino W, Safieh B, Chanson P, Gagnerault MC, Bach JF, Dardennc M: Growth hormone and insulin-like growth lac-tor-I stimulate hormonal function and proliferation of thymic epithelial cells, J Clin Endocrinol Metab 1992:75:183-188.
26. Cross RJ, Bryson JS, Roszman TL: Immunologic disparity in the hypopituitary dwarf mouse, J Immunol 1992;148:1347-1352.
27. Taub DD, Tsarfaty G, Lloyd AR, Durum SK, Longo DL, Murphy WJ: Growth hormone promotes human T cell adhesion and migration to both human and murine matrix proteins in vitro and directly promotes xenogeneic engraftment, J Clin Invest 1994:94:293-300.
28. Idzerda RL, March CJ, Mosley B, Lyman SD, Vanden Bos T, Gimpel SD, Din WS, Grabstein KH, Widmer MB, Park LS, Cosman D, Beckmann MP: Human interleukin 4 receptor confers biological responsiveness and defines a novel receptor superfamily, J Exp Med 1990: 171:861-873.
29. Cosman D, Lyman SD, Idzerda RL, Beckmann MP, Park LS, Goodwin RG, March CJ: A new cytokine receptor superfamily, Trends Bio-chemSci 1990;15:265-270.
30. Bazan JF: Structural design and molecular evolution of a cytokine receptor superfamily, Proc Nail Acad Sci USA 1990:87:6934-6938.
31. Ihle JN: The Janus kinase family and signaling through members of the cytokine receptor superfamily, Proc Soc Exp Biol Med 1994; 206:268-272.
32. Kelly PA, Goujon I, Sotiropoulos A, Diner-stein H, Esposito N, Edery M, Finidori J, Pos-lel-Vinay MC: The GH receptor and signal transduction, Horm Res 1994:42:133-139.
33. Rotwein P, Gronowski AM, Thomas MI: Rapid nuclear actions of growth hormone, Horm Res 1994:42:170-175.
34. Taniguchi T: Cytokine signaling through non-receptor protein tyrosine kinases, Science 1995:268:251-255.
35. Wang LM, Myers MG, Sun XJ, Aaronson SA, White MF, Pierce JH: IRS-1 - Essential for insulin-stimulated and IL-4-stimulated mito-genesis in hematopoietic cells, Science 1993: 261:1591-1594.
36. Wang LM, Keegan AD, Li W, Licnhard GE, Pacini S, Gutkind JS, Myers MG Jr, Sun XJ, White MF, Aaronson SA, Paul WE, Pierce HI: Common elements in interleukin 4 and insulin signaling pathways in factor-dependent hematopoietic cells, Proc Natl Acad Sci USA 1993; 90:4032-4036.
37. Kelley KW, Arkins S, Li YM, Biragyn A: Growth hormone, insulin-like growth factor I, and immune function; in Muller EE, Cocchi D, Locatelli V (eds): Growth Hormone and Som-atomcdins during Lifespan, Berlin, Springer, 1993. pp 173-192.
38. Kelley KW, Arkins S, Li YM: Role of growth hormone and insulin-like growth factor I in immunoregulation: in Bcreu BB, Walker RF (eds): Growth Hormone II: Basic and Clinical Aspects, Berlin, Springer, 1994. pp 87-103.
39. Landreth KS, Narayanan R, Dorshkind K: Insulin like growth factor-! regulates pro-B cell differentiation, Blood 1992;80:1207-1212.
40. Robbins K, McCabe S, Scheiner T, Strasser J, Clark R, Jardieu P: Immunological effects of insulin-like growth factor-1 Enhancement of immunoglobulin synthesis, Clin Exp Immunol 1994;95:337-342.
41. Jardieu P, Clark R, Monensen D, Dorshkind K: In vivo administration of insulin-like growth factor-1 stimulates primary B lymphopoiesis and enhances lymphocyte recovery after bone marrow transplantation, Immunol 1994; 152:4320-4327.
42. Kimata H, Yoshida A: Effect of growth hormone and insulin-like growth factor-1 on immunoglobulin production by and growth of human B cells, J Clin Endocrinol Metab 1994: 78:635-641.
43. Kimata H, Yoshida A: Differential effect of growth hormone and insulin-like growth factor-1. insulin-like growth factor-II, and insulin on Ig production and growth in human plasma cells Blood 1994:83:1569-1574.
44. Kimata H, Fujimoto M: Growth hormone and insulin-growth factor I induce immunoglobulin (lg)E and lgG4 production by human B cells, J Exp Med 1994:180:727-732.
45. Gulcr HP, Zapf J, Schciwiller E, Froesch ER: Recombinant human insulin-like growth factor-1 stimulates growth and has distinct effects on organ size in hypophysectomizcd rats, Proc Natl Acad Sci USA 1988:85:4889-4893.
46. Thisscn IP, Underwood IE, Mailer D, Maes M, Clemmons DR, Kelelslegers JM: Failure of insulin-like growth factor-1 (IGF-1) infusion to promote growth in protein-restricted rats despite normalization of serum IGF-I concentrations, Endocrinology 1991;128:885-890.
47. Binz K, Joller P, Froesch P, Binz H, Zapf J, Froesch ER, Repopulation of the atrophied thymus in diabetic rats by insulin-like growth factor, Proc Nall Acad Sci USA 1990:87: 3690-3694.
48. Turner ID, Novakofski J, Bechtel PJ: Interaction between hypersomatotrophism and age in the Wistar-Furth rat, Growth 1986:50: 402-417.
49. Li YM, Brunke DL, Dantzer R, Kelley KW: Pituitary epithelial cell implants reverse the accumulation of CD4-CD8- lymphocytes in thymus glands of aged rats, Endocrinology 1992:130:2703-2709.
50. Gjerset RA, Yeatgin J, Volkman SK, Vila V, Arya J, Haas M: Insulin-like growth faclor-l supports proliferation of autocrine thymic lymphoma cells with a prc-T cell phenotype, J Immunol 1990:145:3497-3501.
51. Pepe MG, Ginztion NIC, Lee PDK, Hintz RL, Greenberg PL: Receptor binding and mito-gcnic effects of insulin and insulin-like growth factors I and II for human myeloid leukemia cells J Cell Physiol 1987; 133:219-227.
52. Reiss K, Poreu P, Sell G, Pietrzkowski Ba-serga R: The insulin-like growth factor I receptor is required for the proliferation of hemopoietic cells, Oncogene 1992:7:2243-2248
53. Johnson EW, Jones LA, Kozak RW: Expression and function of insulin-like growth factor receptors on anti-CD3-aclivatcd human T lymphocytes, J Immunol 1992:148:63-71.
54. Kooijman R, Willems M, Dc Haas CJC, Rij-kers GT, Schuurmans ALG, van Buul-OlTers SC, Heijncn GJ, Zegers BJM: Expression of type I insulin-like growth factor receptors on human peripheral blood mononuclear cells, Endocrinology 1992; 131:2244-2250.
55. Rom WN, Piiakko P: Activated alveolar macrophages express the insulin-like growth lac-tor-l receptor, Am J Respir Cell Mol Biol 1991:4:432-439.
56. Fu YK, Arkins S, Fuh G, Cunningham BC, Wells JA, Fong S, Cronin MJ, Dantzer R, Kelley KW; Growth hormone augments superoxide anion secretion of human neutrophils by binding to the prolactin receptor, J Clin Invest 1992:89:451-457.
57. Fu YK, Arkins S, Wang BS, Kelley KW: A novel role of growth hormone anil isulin-like growth factor-1. Priming neutrophils for superoxide anion secretion, J Immunol 1991:146: 1602-1608.
58. Warwick-Davies J, Lowrie DB, Peter JC: Growth hormone is a human macrophage activating factor, J Immunol 1995:154: 1909-1918.
59. Gcffncr ME, Bersch N, Lippe BM, Roscnleld RG, Hintz RL, Golde DW: Growth hormone mediates the growth of T-lymphoblasl cell lines via locally generated insulin-like growth factor-1. J Clin Endocrinol Metals 1990:71: 464-469.
60. Hochberg Z, Hertz P, Maor G, Oikninc J, Avi-ram M: Growth hormone and insulin-like growth factor-1 increase macrophage uptake and degradation of low density lipoprotein, Endocrinology 1992:131:430-435.
61. Merchav S, Tatarsky I, Hochberg Z: Enhance ment of human granulopoiesis in vitro by biosynthetic insulin-like growth factor-l/somato-medin C and human growth hormone, J Clin Invest 1988:81:791-797.
62. Merchav S, Tatarsky I, Hochberg Z: Enhancement of crythropoicsis in vitro by human growth hormone is mediated by insulin-like growth factor, Br J Haematol 1988:70: 267-271.
63. Werther GA, Haynes K, Johnson GR: Insulinlike growth factors promote DNA synthesis and support cell viability in fetal hemopoietic tissue by paracrine mechanisms, Growth Factors 1990;3:171-179.
64. Claustres M, C’haielain P, Sultan C: Insulinlike growth factor I stimulates human erythroid colony formation, J Clin Endocrinol Metab 1987:65:78-82.
65. Arkins S, Reheiz N, Biragyn A, Reese DL, Kelley KW: Murine macrophages express abundant insulin-like growth faclor-l class I Ea and Eh transcripts, Endocrinology 1993:133: 2334-2343.
66. Arkins S, Liu Q, Kelley KW: Theoretical and functional aspects of measuring insulin-like growth factor-1 mRNA expression in myeloid cells, Immunomethods 1994:5:8-20.
67. Arkins S, Rebeiz N, Brunke-Reese DL, Biragyn A, Kelley KW: Intcrferon-y inhibits macrophage insulin-like growth faclor-l synthesis at the transcriptional level, Mol Endocrinol 1995;9:350-360.
68. Arkins S, Rebeiz N, Brunke-Reese DL, Min-shall C, Kelley KW: The colony-stimulating factors induce expression of insulin-like growth factor-1 messenger ribonucleic acid during hematopoicsis, Endocrinology 1995: 136:1153-1160.
69. Geenen V, Achour I, Robert F, Vandcrsmisscn E, Sodoyez JC, Defresne MP, Boniver J, Lefebvre PJ, Franchimont P: Evidence that insulin-like growth factor 2 (IGF-2) is the dominant thvrnic peptide of the insulin superfamily, Thymus 1993:21:115-127.
70. Rom WN, Basset P, Fells GA, Nukiwa T, Trap-nell BD, Crystal RG: Alveolar macrophages release an insulin-like growth factor-I-lypc molecule, J Clin Invest 1988:82:1685-1693.
71. Kirstein M, Aston C, Hintz R, Vlassara H: Receptor-specific induction of insulin-like growth factor I in human monocytes by advanced glycosylalion end produet-modified proteins, J Clin Invest 1992:90:439-146.
72. Noble PW, Lake FR, Henson PM, Riches DWH: Hyaluronate activation of CD44 induces insulin-like growth factor-1 expression by a tumor necrosis factor-«-dcpendcni mechanism in murine macrophages, J Clin Invest 1993:91:2368-2377.
73. Lake FR, Noble PW, Henson PM, Riches DWH: Functional switching of macrophage responses to tumor necrosis factor-Ot (TNFcO by interferons, J Clin Invest 1994:93:1661-1669.
74. Ellis HM, Horvitz, HR: Genetic control of programmed cell death in the nematode C-elegans, Cell 1986:44:817-829.
75. Cohen PL, Eisenburg RA: Single gene models of systemic autoimmunity and lymphoprolifer-ative disease, Annu Rev Immunol 1991:9: 243-270.
76. Raff MC: Social controls on cell survival and cell death, Nature 1992:356:3521-3529.
77. Williams GT, Smith CA, Spoonccr E, Dexter TM, Taylor DR: Haemopoielic colony stimulating factors promote cell survival by suppressing apoptosis, Nature 1990;343:76-79.
78. Kourv MJ, Bondurani MC: Erythropoietin retards DNA breakdown and prevents programmed death in erythroid progenitor cells, Science 1990:248:378-381.
79. Fairhiim IJ, Cowling GJ, Reipert BM, Dexter TM: Suppression of apoptosis allows differentiation and development of a nuiltipoient hemopoietic cell line in the absence of added growth factors, Cell 1993:74:823-832.
80. Wyllie AH: Cell death, Ini Ree Cytol Suppl 1986:17:755-768.
81. Cohea JJ, Duke RC: Apoptosis and programmed cell death in immunity, J Immunol 1992:10:267-293.
82. Smith CA, Williams GT, Kingston R, Jenkin-son EJ, Owen JJT: Antibodies to CD3/T-cell receptor complex induce death by apoptosis in immature T-cells in thymic cultures, Nature 1989:337:181-184.
83. Newell MK, Hauglm LJ, Maroun CR, Julius Mil: Death of mature T-cells by separate ligation of CD4and thcT-cell receptor for antigen, Nature 1990:347:286-288.
84. Nieto MA, Gonzalez A, Lopez-Rivas A, Diaz-Kspaila F, Gambon F: 11.-2 protects against anti-CD, J induced cell death in human medullary thymocytes, J Immunol 1990:145: 1364-1368.
85. Liu YJ, Joshua DE, Williams GT, Smith CA, Gordon J, MacLennan ICM: Mechanism of antigen driven selection in germinal centres, Nature 1989:342:929-931.
86. Rodrguez-Tarduchy G, Collins MKL, Garcia I, Lopez-Rivas A: Insulin-like growth faclor-l inhibits apoptosis in 11.-3-dependent hemopoietic cells, J Immunol 1992:149:535-540.
87. Mula K, Krantz SB: Apoptosis of human cryth roid colony-forming cells is decreased by stem cell factor and insulin-like growth factor I as well as erythropoietin, J Cell Physiol 1993: 156:264-271.
88. Ralajezak VIZ, Kuezvnski WI, Onodera K, Moore J, Ratajczak J, Kregenow DA, DeRiel K, Gewirlz AM: A reappraisal of the role ol insulin-like growth factor I in the regulation of human hematopoicsis, J Clin Invest 1994:94: 320-327.
89. Minshall C, Arkins S, Kelley KW: Inhibition of apoptosis by IGF-I in murine bone marrow and myeloid progenitor cells, Proceedings of the 9th International Congress of Immunology, San Francisco, 1995.
90. Barrcs BA, Hart IK, Coles HSR, Bume JF, Voyvodic JT, Richardson WD, Raff MC: Cell death and control of cell survival in the oligodendrocyte lineage, Cell 1992:70:31-46.
91. Baserga R: Oncogenes and the strategy ol growth factors, Cell 1994:79:927-930.